Prenatal glucocorticoid exposure and postnatal adaptation in premature newborn baboons ventilated for six days

Area of Science:

• Neonatal physiology
• Pharmacology
• Developmental biology

Background:

• Premature infants often experience renal and cardiovascular dysfunction.
• Prenatal corticosteroid administration is used to promote fetal lung maturation.
• The long-term effects of prenatal betamethasone on neonatal organ function require further investigation.

Purpose of the Study:

• To investigate the sustained effects of prenatal betamethasone (BETA) on renal, cardiovascular, and endocrine function in preterm ventilated baboons through day 6 of life.
• To determine if initial improvements in renal and cardiovascular function observed at 24 hours are maintained.
• To assess the impact of BETA on kidney Na, K-ATPase activity.

Main Methods:

• Pregnant baboons received either saline or betamethasone (6 mg) at 48 and 24 hours before preterm delivery (125 days' gestation).
• Newborn baboons were ventilated for 6 days.
• Renal, cardiovascular, and endocrine functions were assessed, including mean arterial blood pressure (MAP), glomerular filtration rate (GFR), and kidney Na, K-ATPase activity.

Main Results:

• Mean arterial blood pressure (MAP) and glomerular filtration rate (GFR) were significantly higher in the BETA-exposed group at 24 hours after delivery.
• Kidney Na, K-ATPase activity was elevated in the BETA group by day 6.
• No other significant differences in measured parameters were observed between the groups by day 6.

Conclusions:

• Prenatal betamethasone exposure in preterm baboons transiently increases MAP and GFR on day 1.
• The beneficial effects of prenatal BETA on MAP and GFR are not sustained through day 6.
• Prenatal BETA exposure leads to increased kidney Na, K-ATPase activity by day 6.